Does RUXOLITINIB Cause Circulatory collapse? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Circulatory collapse have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
26
Reports of Circulatory collapse with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
14
Deaths
20
Hospitalizations
How Dangerous Is Circulatory collapse From RUXOLITINIB?
Of the 26 reports, 14 (53.8%) resulted in death, 20 (76.9%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Circulatory collapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Circulatory collapse?
AMLODIPINE (430)
METFORMIN (338)
QUETIAPINE (297)
BISOPROLOL (248)
PROPOFOL (241)
METOPROLOL (223)
FUROSEMIDE (219)
CLOPIDOGREL BISULFATE (206)
PREDNISOLONE (204)
IBUPROFEN (203)
Which RUXOLITINIB Alternatives Have Lower Circulatory collapse Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE